A NOVEL POLYPEPTIDE, A HUMAN CD63 ANTIGEN 56.87 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE

Details for Australian Patent Application No. 2002218969 (hide)

Owner SHANGHAI BIOWINDOW GENE DEVELOPMENT INC.

Inventors XIE, Yi; MAO, Yumin

Pub. Number AU-A-2002218969

PCT Pub. Number WO2002/055551

Priority 01 1 05183.3 10.01.01 CN

Filing date 8 January 2002

Wipo publication date 24 July 2002

International Classifications

C07K 014/435 Peptides having more than 20 amino acids - from animals

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

A61K 038/17 Medicinal preparations containing peptides - from animals

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002218969

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002218970-METHOD FOR RECOVERING LITHIUM CHLORIDE FROM BRINE AND INSTALLATION FOR CARRYING OUT SAID METHOD

2002218968-BINOCULAR MYOPIA PHYSIOTHERAPY APPARATUS